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The susceptibilities of 54 clinical isolates of Neisseria meningitidis to penicillin, cefotaxime, ceftriaxone,
cefepime, imipenem, ciprofloxacin, chloramphenicol, and rifampin were determined by the microdilution
method in both cation-adjusted Mueller-Hinton broth (CAMHB) and Haemophilus test medium (HTM). Poor
growth was observed in 16.6 and 9% of the strains in CAMHB and HTM, respectively. As a result, the growth
of the 54 N. meningitidis strains was evaluated in three other commercially available batches of CAMHB and
in one in-house batch of HTM. Poor growth was observed for 9.3 to 16.6% of the strains in all four batches.
More important, three of the CAMHB batches failed to support growth for 3.7 to 33.3% of the strains; 3.7% of
the strains did not grow in the in-house-prepared HTM. Ten (18.7%) strains were relatively resistant to
penicillin (RRP; MIC, >0.125 mg/ml) in CAMHB and 13 (24%) strains were RRP in HTM. The percentages
of agreement obtained by using CAMHB as the reference ranged from 78% for cefepime to 100% for ceftri-
axone. Seven minor errors were observed for penicillin; five of them were for strains susceptible to penicillin
in CAMHB and RRP in HTM. All strains were susceptible to the other antimicrobial agents evaluated. The
growth of N. meningitidis was also evaluated in four batches of Mueller-Hinton agar (MHA). In two of them,
3.7 and 44.4% of the strains did not grow, and considering all four batches, 5.5 to 11.1% grew poorly. All strains
grew adequately in MHA supplemented with blood (MHA-b). The activities of penicillin and cefotaxime were
also evaluated by the E-test in MHA and MHA-b. The proportion of RRP strains were 24% in MHA and 59%
in MHA-b. For penicillin, the percentages of agreement of the E-test with the microdilution method in CAMHB
(reference) were 64.8 and 70.3% in MHA and MHA-b, respectively. For cefotaxime, the agreement was 98.1%.
Minor errors for the penicillin MIC were detected for 38% of the strains tested. Further studies are needed to
define adequate culture media for reference methods to evaluate the susceptibility of N. meningitidis to
antimicrobial agents.
Neisseria meningitidis is an important cause of meningitis and
community-acquired septicemia in children (23). Penicillin G
has been considered the treatment of choice for infections
caused by this organism. Over the past decade, N. meningitidis
strains with decreased susceptibility to penicillin (MICs of pen-
icillin G, $0.125 mg/ml) have been described in Europe (22,
25–27, 30), South Africa (3), South America (13), and North
America (11, 24). The incidence in Spain of meningococci with
decreased susceptibility to penicillin increased from 0.4% in
1985 (25) to 67% in 1994 (9). Resistance in these strains is
related to altered forms of PBP 2 (14). A few b-lactamase-
producing strains have also been described in South Africa,
Spain, and Canada (3, 7, 8, 20).
The National Committee for Clinical Laboratory Standards
(NCCLS) has recommended microdilution (with cation-ad-
justed Mueller-Hinton broth [CAMHB]) or agar dilution (with
Mueller-Hinton agar [MHA]) for susceptibility testing of N.
meningitidis (17), but several investigators have observed that
some strains grow poorly in Mueller-Hinton media (13). For
this reason, other media, including Haemophilus test medium
(HTM) (13), GC agar (29), and MHA supplemented with
blood (MHA-b) (4, 5), have also been used. There are no
specific guidelines from NCCLS regarding the susceptibility of
meningococci by disk diffusion, but the use of 1-mg oxacillin
and 2-U penicillin G disks has been proposed for the screening
of N. meningitidis moderately susceptible to penicillin (and/or
ampicillin) (4, 5). A more recent possibility for the quantitative
determination of antimicrobial activity is the E-test. This sys-
tem can be used to study the susceptibilities of microorgan-
isms, including fastidious bacteria such as Haemophilus influ-
enzae or Streptococcus pneumoniae, and is particularly useful
when limited numbers of antimicrobial agents are tested (15).
When compared with the agar dilution method, the E-test has
been shown to be a reliable method of evaluating the antimi-
crobial susceptibility of N. meningitidis (10, 12).
The present study was undertaken to evaluate the capabili-
ties of different culture media (and batches) commonly used in
susceptibility testing assays to support the growth of N. men-
ingitidis. Moreover, the susceptibility patterns of N. meningiti-
dis organisms isolated in Seville, in southern Spain, and the
usefulness of the E-test as a method of recognizing N. menin-
gitidis isolates relatively resistant to penicillin were also evalu-
ated.
(This work was presented in part at the 35th Interscience
Conference on Antimicrobial Agents and Chemotherapy, San
Francisco, Calif., 17 to 20 September 1995 [19].)
MATERIALS AND METHODS
Bacteria. Fifty-four strains of N. meningitidis isolated between 1992 and 1994
from cerebrospinal fluid (24), blood (8), joint fluid (1), and pharyngeal exudates
(21) at the Microbiology Laboratories of both the University Hospital Virgen
Macarena and the University Hospital Virgen de Valme in Seville (Spain) were
used. The strains were identified by standard bacteriological methods, including
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Gram stain, oxidase, aminopeptidase activity, and carbohydrate degradation tests
(16). Serogrouping was performed by agglutination with commercial antisera
(Difco Laboratories, Detroit, Mich.). b-Lactamase activity was assayed with the
chromogenic cephalosporin nitrocefin. After identification, the bacteria were
maintained in 10% glycerol in tryptic soy broth at 2708C until they were ready
for use. Before they were used, the bacteria were subcultured twice on Columbia
agar plates supplemented with 5% sheep blood agar at 358C in 5% CO2. Staph-
ylococcus aureus ATCC 29213, Escherichia coli ATCC 25299, and Pseudomonas
aeruginosa ATCC 27853 were used as control strains in microdilution assays, and
S. aureus ATCC 25923 was also studied for the E-test.
Media. The growth of the 54 strains of N. meningitidis was evaluated in several
media. Four batches of Mueller-Hinton broth (MHB, three from Difco [11497,
59462 JG, and 69437 JC], and one from Oxoid [040-46950; Oxoid, Basingstoke,
England]), two batches of HTM (one from BBL [I5EPVT; Becton Dickinson,
Cockeysville, Md.] and one prepared in house according to NCCLS guidelines),
and four batches of MHA (three from Difco [34970 JD, 63154 JC, and 65892 JA]
and one from Oxoid [060-48017]) were evaluated.
MHA (Difco) from batch 34970 JD was used to prepared MHA supplemented
with 5% sheep blood (MHA-b).
The culture media were inoculated and incubated according to NCCLS guide-
lines for susceptibility testing of N. meningitidis. The growth was evaluated
independently by three different observers.
According to the results obtained from these experiments (see below), batch
34970 JD of MHA, batch 11497 of MHB, and batch I5EPVT of HTM were used
for susceptibility testing assays.
Microdilution assay. An in-house microdilution method was used. We fol-
lowed the guidelines described by NCCLS (17) using either CAMHB or HTM.
The following antimicrobial agents were used as powders of known potency:
penicillin G (Sigma, St. Louis, Mo.), cefotaxime (Hoechst, Barcelona, Spain),
ceftriaxone (Sigma), cefepime (Bristol Myers Squibb, Madrid, Spain), imipenem
(Merck Sharp & Dohme, Madrid, Spain), ciprofloxacin (Bayer AG, Barcelona,
Spain), chloramphenicol (Sigma), and rifampin (Sigma). Twofold dilutions
across a range of 0.008 to 16 mg/ml were used. The inoculum (5 3 104 CFU per
well) was prepared in CAMHB from cultures grown (for 20 to 24 h) on Columbia
agar with 5% sheep blood. The plates were incubated at 358C in a 5% CO2
atmosphere, and the MIC results were read after 24 h.
E-test. Plates containing either MHA or MHA-b were used for the E-test. The
inoculum was prepared by suspending bacteria grown on Columbia agar with 5%
sheep blood for 24 h in CAMHB to a concentration of about 108 CFU/ml. The
plates were inoculated with a cotton swab according to NCCLS guidelines for the
disk diffusion assay (18). E-test strips (Biodisk, Solna, Sweden) of penicillin G
and cefotaxime were applied to the surfaces of the plates. For each microorgan-
ism, one 150-mm-diameter plate of each medium was used, and two strips were
applied to each agar surface. The plates were incubated at 358C in a 5% CO2
atmosphere, and the MIC results were read after 24 h.
Evaluation criteria. Because of the absence of accepted breakpoints for the
assignment of N. meningitidis to interpretive categories, definitions of suscepti-
bility were as follows: for penicillin an MIC of #0.06 mg/ml indicated suscepti-
bility, an MIC of 0.125 to 1 mg/ml indicated relative resistance to penicillin
(RRP), and an MIC of$2 mg/ml indicated resistance. For all other antimicrobial
agents, published NCCLS breakpoint definitions were used (17). For comparison
of the results determined by the E-test, the MICs obtained by this method were
rounded up to the next higher twofold dilution.
RESULTS
Thirty-four strains were serogroup B, 18 were serogroup C,
and 2 were nonagglutinable. None of the strains produced
b-lactamase.
The percentage of strains that either grew poorly or that did
not grow at all in the different media and batches is presented
in Table 1. Remarkable differences in the percentages of
strains which did not grow in the four media evaluated in the
study were observed. These ranged from 0 to 44.4% in MHA,
from 0 to 33.3% in CAMHB, and from 0 to 3.7% in HTM. All
the strains grew properly on MHA-b.
Data on the antimicrobial susceptibility of N. meningitidis, as
determined in CAMHB, are presented in Table 2. When con-
sidering all 54 N. meningitidis strains, the MIC at which 90% of
isolates are inhibited (MIC90) for penicillin was 0.125 mg/ml.
Ten (18.7%) strains were RRP. Eight of these strains were
serogroup B (24% of serogroup B strains) and two were sero-
group C (11% of serogroup C strains). All strains were sus-
ceptible to the other antimicrobial agents evaluated. The ac-
tivity of imipenem was lower than that of the broad-spectrum
cephalosporins.
When comparing the activities of the antimicrobial agents
evaluated against penicillin-susceptible strains and RRP
strains, it was found that the MIC90s of rifampin and imipenem
for the latter group were four times or greater and two times
higher, respectively, than those for penicillin-susceptible
strains. Moreover, the MIC90s of rifampin for pharyngeal iso-
lates were three dilution steps or more compared with those
obtained for invasive strains (0.06 versus #0.008 mg/ml).
Nine of the 54 strains (16.6%) grew poorly in CAMHB,
which made the reading of the endpoints for MIC determina-
tions difficult. Therefore, we also evaluated HTM as an alter-
native medium for the microdilution assay. Even in this me-
dium, poor growth of 5 (9%) strains was observed, and two of
these strains also grew poorly in CAMHB. Thirteen (24%)
strains were RRP in HTM, with five of them corresponding to
strains which were susceptible in CAMHB.
The distribution of the differences in the MICs of the anti-
microbial agents evaluated in CAMHB or HTM are presented
in Table 3. The percentages of agreement within 61 twofold
dilution step by using CAMHB as the reference ranged from
78% for cefepime to 100% for ceftriaxone. For penicillin the
percentage of agreement was 81%. In this medium, 13 (24%)
strains were RRP. Seven (13%) minor errors were observed
for penicillin. No discrepancies were observed for the other
antimicrobial agents.
With the E-test, the MIC90s of penicillin in MHA and
MHA-b were 0.25 and 0.38 mg/ml, respectively. By this
TABLE 1. N. meningitidis strains that grew poorly or that did not
grow in different culture media
Medium
Percent
Poor growth No growth
CAMHB
Difco batch 11497 16.6 0
Difco batch 59462 JG 13.0 20.4
Difco batch 69437 JC 9.3 33.3
Oxoid batch 040-46950 14.8 3.7
HTM
BBL batch 15EPVT 9.0 0
In-house batch 16.6 3.7
MHA
Difco batch 34970 JD 5.5 0
Difco batch 63154 JC 11.1 0
Difco batch 65892 JA 9.3 3.7
Oxoid batch 060-48017 11.1 44.4
MHA-b 0 0
TABLE 2. Antimicrobial susceptibilities of N. meningitidis to eight




Penicillin 0.03 0.125 #0.008–0.25
Cefotaxime #0.008 #0.008 #0.008–0.03
Ceftriaxone #0.008 #0.008 #0.008–0.015
Cefepime #0.008 0.06 #0.008–0.06
Imipenem 0.125 0.25 0.015–0.25
Ciprofloxacin #0.008 #0.008 #0.008–0.06
Chloramphenicol 0.5 1 0.125–2
Rifampin #0.008 0.015 #0.008–0.125
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method, the percentages of RRP strains were 24% in MHA
and 59% in MHA-b. Sixteen of the 54 strains (29%) including
11 from cerebrospinal fluid, 3 from pharyngeal exudates, and 2
from blood cultures were susceptible to penicillin in this me-
dium but were RRP when they were tested on MHA-b. When
comparing the results obtained in both media, no differences in
the MICs (within the ranges that we studied) of cefotaxime
determined by the E-test were observed.
The distribution of differences in the MICs of penicillin
determined by the reference microdilution method in
CAMHB and the E-test in either MHA or MHA-b are pre-
sented in Table 4. The percentages of agreement were 65 and
70% in MHA and MHA-b, respectively. When cefotaxime was
considered, the agreement of the E-test with the reference
microdilution method was 98.1% in both media.
DISCUSSION
The emergence of resistance to penicillin in a few b-lacta-
mase-producing strains of N. meningitidis, and, in particular,
the appearance of RRP strains in different countries (3, 11, 13,
22, 24–27), could throw open the question of the empirical
treatment of meningococcal diseases with penicillin.
The correct evaluation of the resistance of N. meningitidis to
penicillin and other antimicrobial agents should be based on a
standardized methodology that allows comparison of results
from different laboratories. At the moment NCCLS recom-
mends the use of either an agar dilution method with MHA or
a broth microdilution assay in CAMHB (17).
Nevertheless, the results from the present study show the
great variability in the growth of N. meningitidis in different
MHA and CAMHB culture media and in different batches of
the same medium. The only medium allowing sufficient growth
of N. meningitidis was MHA-b. These results question the
usefulness of the culture media currently recommended by
NCCLS and suggest that further studies are needed in order to
establish the medium of choice for susceptibility testing of N.
meningitidis.
We used the broth microdilution assay to study the activities
of eight antimicrobial agents against 54 isolates of N. menin-
gitidis isolated in southern Spain. In our study, the prevalence
of RRP strains was 18.7% in CAMHB, but it was 24% in both
HTM and MHA and 59% in MHA-b. Other investigators from
Spain have reported prevalences ranging from 48% (4) to 67%
(9) by disk diffusion and agar dilution methods, respectively.
Considering the results obtained in CAMHB, we have not
observed a higher percentage of serogroup C strains among
the RRP strains, as was previously reported in our country (1,
2). Although we evaluated only 10 RRP strains, decreased
activity of rifampin (and, to a lesser extent, that of imipenem)
against these strains was observed. This decreased activity of
rifampin was observed in pharyngeal isolates but not in inva-
sive strains. The explanation for this finding remains obscure.
Since 16.6% of the N. meningitidis strains included in the
study grew poorly in CAMHB, an alternative medium, HTM,
was also evaluated in the microdilution assay. Although better
growth was observed in HTM, 9% of the strains nonetheless
grew poorly in this medium. When the results obtained with
HTM were compared with those obtained with CAMHB, the
agreements for the different antimicrobial agents ranged from
78% for cefepime to 100% for ceftriaxone. Minor errors were
observed for penicillin (13%) but not for the other antimicro-
bial agents tested, and in fact, five strains which were suscep-
tible in CAMHB were RRP in HTM. Differences in growth in
both media may explain these results. Lopardo et al. (13) also
observed a better growth of N. meningitidis in HTM than in
MHB, but the differences in the MICs of penicillin observed
with both media did not differ by more than 1 dilution step.
Both the disk diffusion assay and the E-test have been
proved to be cost-effective for evaluating the activity of peni-
cillin against N. meningitidis. Disks of b-lactams, including ox-
acillin (1 mg) (4), penicillin (2 or 10 U) (4), and amdinocillin
(10 mg) (21), have been used to separate penicillin-susceptible
and RRP strains of N. meningitidis, but the clinical usefulness
of the results obtained by these screening tests is controversial
(28). With the E-test, the inclusion of a broad-spectrum ceph-
alosporin strip together with the penicillin strip will allow us to
determine the activities of the antimicrobial agents more com-
monly used in the treatment of meningococcal disease.
The agreement of the E-test in MHA with the standard
microdilution method in CAMHB within 61 dilution step was
TABLE 3. Distribution in differences of MICs of eight antimicrobial agents for 54 strains of N. meningitidis determined in CAMHB
(reference) and HTM
Antimicrobial agent
% Isolates with the following differences in MIC:
% Agreement
#23 22 21 0 11 12 $13
Penicillin 5.6 3.7 31.5 38.8 11.1 9.23 0 81.4
Cefotaxime 0 1.8 0 94.5 3.7 0 0 98.2
Ceftriaxone 0 0 3.7 94.5 1.8 0 0 100
Cefepime 5.6 13.0 18.5 55.5 7.4 0 0 81.4
Imipenem 11.1 9.3 40.8 25.9 11.1 1.8 0 77.8
Ciprofloxacin 1.8 1.8 1.8 90.9 3.7 0 0 96.5
Chloramphenicol 3.7 0 7.4 46.3 29.6 13.0 0 83.3
Rifampin 0 0 5.6 88.9 1.8 3.7 0 96.3
TABLE 4. Difference in MICs of penicillin determined by the reference microdilution method in CAMHB and the E-test determined in
either MHA or MHA-b
Medium
% Isolates with the following differences in MICs:
% Agreement
#23 22 21 0 11 12 $13
MHA 1.9 0 7.4 25.9 31.5 28.8 5.5 64.8
MHA-b 1.9 7.4 5.5 18.5 46.3 13.0 7.4 70.3
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only 64.8%. All strains grew on MHA-b, but the agreement of
the E-test in this medium with the microdilution method in
CAMHB was still only 70.3%. These disagreements are related
to increased MICs determined by the E-test. In fact, 34.3 and
20.4% of the MICs determined by the E-test in MHA and
MHA-b, respectively, were $2 dilution steps higher than the
MICs determined by the microdilution method in CAMHB.
Data were also discrepant when results from the E-test in
MHA and MHA-b were compared: 38% of minor errors were
caused by strains susceptible to penicillin in MHA but RRP in
MHA-b. We might speculate that the poor growth observed
for some strains of N. meningitidis in CAMHB and MHA is the
cause of such low levels of agreement between the E-test and
the microdilution method. Other investigators have obtained
higher levels of agreement when the E-test was compared with
the agar dilution method (10, 12, 21). Carroll et al. (6) have
also reported a high degree of correlation of the E-test with the
reference microdilution method, but only strains susceptible to
penicillin (#0.06 mg/ml) were evaluated by those investigators.
Our results suggest that it is very difficult to establish
whether an isolate of N. meningitidis is RRP. Fortunately, the
clinical manifestations in and outcomes for patients infected
with RRP strains are similar to those for patients infected with
strains that are not resistant, and it has been indicated that
similar treatments may be used for both N. meningitidis isolates
that are penicillin susceptible and RRP (1). Molecular meth-
ods based on the detection of altered PBP 2 could help to
elucidate whether a particular strain should be considered
RRP, but until this is done, further studies on the activity of
penicillin against N. meningitidis are warranted.
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